IP Library Granted Patent US 10,266,865
Granted Patent B2
US 10,266,865 · App. 14/636,082 · Granted Apr 23, 2019

Methods for in vitro joining and combinatorial assembly of nucleic acid molecules

Inventors: Daniel G. Gibson (Carlsbad, CA); Hamilton O. Smith (San Diego, CA); Clyde A. Hutchison (La Jolla, CA); Lei Young (Gaithersburg, MD); J. Craig Venter (La Jolla, CA)
Assignee: Synthetic Genomics, Inc.
C12P19/34C12N15/10C12N15/1027C12N15/64C12N15/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,865
App. No.
14/636,082
Granted
Apr 23, 2019
Kind
B2
Abstract

The present invention relates to methods of joining two or more double-stranded (ds) or single-stranded (ss) DNA molecules of interest in vitro, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule of each pair share a region of sequence identity. The method allows the joining of a large number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes. It can be used, e.g., to join synthetically produced sub-fragments of a gene or genome of interest. Kits for performing the method are also disclosed. The methods of joining DNA molecules may be used to generate combinatorial libraries useful to generate, for example, optimal protein expression through codon optimization, gene optimization, and pathway optimization.

Claims (27)

1. An in vitro method of joining a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, said method comprising contacting in vitro the two or more DNA molecules in a single vessel with reaction components comprising

(a) an isolated non-thermostable 3′ to 5′ exonuclease active in the presence of dNTPs,

(b) a crowding agent selected from the group consisting of polyethylene glycol (PEG) and dextran,

(c) a heat-activated DNA polymerase comprising an inactivating moiety conjugated to the polymerase in a temperature-sensitive manner,

(d) a thermostable ligase,

(e) a mixture of dNTPs, and

(f) a suitable buffer,

under conditions that are effective for joining the two or more DNA molecules to form a first assembled dsDNA molecule in a one-step thermocycled reaction.

2. The method of claim 1 wherein the heat-activated DNA polymerase is active above 65° C.

3. The method of claim 2 wherein the non-thermostable exonuclease is inactive above 65° C.

4. The method of claim 1 , wherein the exonuclease of (a) is Exonuclease III.

5. The method of claim 1 , wherein DNA polymerase of (c) is heat-activated by the removal of the inactivating moiety bound to the polymerase in a temperature-sensitive manner.

6. The method of claim 5 wherein the inactivating moiety is an antibody bound to the DNA polymerase.

7. The method of claim 5 wherein the inactivating moiety is biotin bound to the DNA polymerase.

8. The method of claim 3 , wherein

the crowding agent of (b) is PEG, and/or

the ligase of (d) is Taq ligase.

9. The method of any of claim 1 , further comprising repeating the method to join a second set of two or more DNA molecules to one another to obtain a second assembled DNA molecule, and then joining the first and the second assembled DNA molecules to obtain a third assembled ds DNA molecule.

10. The method of claim 1 comprising a phase conducted at about 30-45° C. wherein the DNA polymerase is inactive and the exonuclease is active, and a phase conducted above 65° C. wherein the DNA polymerase is active and the exonuclease is inactive.

11. The method of claim 1 wherein the two or more DNA molecules are contacted with the components (a) (f) at about 37° C., and the temperature is subsequently raised and the components incubated at about 75° C.

12. The method of claim 3 wherein when the temperature is lowered to about 60° C. the ligase is active.

13. The method of claim 1 wherein the ligase is active at a temperature of 75° C.

14. The method of claim 1 wherein the two or more DNA molecules are contacted with the components (a) (f) at a temperature of 30-45° C., and the temperature is subsequently raised to above 65° C.

15. The method of claim 14 further comprising that subsequent to raising the temperature to above 65° C., the temperature is subsequently lowered to about 60° C.

16. The method of claim 3 wherein the exonuclease of (a) is exonuclease III.

17. The method of claim 1 , wherein the crowding agent is polyethylene glycol (PEG).

18. The method of claim 3 , wherein the crowding agent is polyethylene glycol (PEG).

Assignments (8)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
Continuity (7)
Division 12371543 · Feb 13, 2009
Provisional Application 61142101 · Dec 31, 2008
Provisional Application 61098202 · Sep 18, 2008
Provisional Application 61052614 · May 12, 2008
Provisional Application 61064107 · Feb 15, 2008
Provisional Application 61029312 · Feb 15, 2008
Related Publication 20150240280A1 · Aug 27, 2015